Metabolic state determines the brain and direct islet effects of liraglutide on enhanced insulin secretion
Chiara Saponaro(University of Pisa), Caroline Bonner(Inserm), François Pattou(Inserm), Markus Schwaninger(University of Lübeck), Markus Mühlemann(Inserm), Lakshmi Kothegala(Churchill Hospital), Rubén Nogueiras(Universidade de Santiago de Compostela), Ana Acosta-Montalvo(Inserm), Begoña Porteiro(Universidade de Santiago de Compostela), Eve Wemelle(Inserm), Frank W. Pfrieger(Institut des Neurosciences Cellulaires et Intégratives), Mónica Imbernón(Universidade de Santiago de Compostela), Ben Jones(Hammersmith Hospital), Julien Thévenet(Inserm), Eleonora Deligia(Inserm), Isaline Louvet(Inserm), Claude Knauf(Université Toulouse III - Paul Sabatier), Gianni Pasquetti(Inserm), Lorea Zubiaga(Inserm), Vincent Prévot(Inserm), Julie Kerr‐Conte(Inserm), F. Auger(Direction des Energies), Patrik Rorsman(University of Oxford), Maria Moreno Lopez(Inserm), Iona Davies(Imperial College London), Shiqian Chen(Imperial College London), Bart Staels(Inserm), Nathalie Dellalau(Inserm), Valéry Gmyr(Inserm)
Cited by 0
Related Papers
Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
|Journal of Hepatology|2014|1.5k
Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1
|Journal of Biological Chemistry|1999|1.1k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
PPAR control of metabolism and cardiovascular functions
|Nature Reviews Cardiology|2021|901